“Australia's speediest news portal”
One News Page
> >

Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy

Reuters Tuesday, 14 November 2017
SEOUL (Reuters) - A unit of healthcare conglomerate Johnson & Johnson has dropped a lawsuit it filed to block a copy of its rheumatoid arthritis drug Remicade produced by South Korea's Samsung Bioepis Co Ltd from being sold in the United States.
Share on
Share on
Post on 
Share by

You Might Like

Tweets about this

Other recent news in Health

Florida Is In A State Of Emergency As Subtropical STORM ALBERTO ApproachesThe Latest: UK leader hails IRELAND ABORTION VOTE result
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+